| Syntara Limited (SNT) ORDINARY FULLY PAID |
Health Care |
$120 |
Quarterly Appendix 4C Cash Flow Report
|
30 Jul 2024 10:21AM |
$0.040 |
$0.074 |
risen by
85%
|
|
SNT - Price-sensitive ASX Announcement
Full Release
Key Points
- Company experienced a net cash outflow of $4.236 million from operating activities.
- Research and development expenses amounted to $2.097 million.
- Staff costs were $1.838 million.
- Received R&D tax incentives of $5.193 million during the period.
- Total available funding at the end of the quarter was $3.520 million.
- Estimated 0.8 quarters of funding available at current operating cash flow rates.
- Secured firm commitments to raise approximately A$5.0 million in a two-tranche placement.
- Expected to receive $3.6 million from 2024 R&D tax credit and $929,000 from security deposit return.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| IGO Limited (IGO) ORDINARY FULLY PAID |
Materials |
$3,256 |
June 2024 Quarterly Results Presentation
|
30 Jul 2024 10:21AM |
$5.670 |
$4.300 |
fallen by
24.16%
|
|
| Artemis Resources Limited (ARV) ORDINARY FULLY PAID |
Materials |
$18 |
Quarterly Activities Report
|
30 Jul 2024 10:20AM |
$0.010 |
$0.007 |
fallen by
30%
|
|
ARV - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant progress at Karratha Lithium Project with high-grade rock chip assays
- High-grade lithium oxide percentages at Mt Marie, highest at 4.63%
- Extended mineralization at Osborne Lithium Project
- Multiple gold targets identified in Karratha Gold Precinct
- High-grade gold assays from Orpheus zone
- Elizabeth Henson appointed as non-executive director
- Successful $2.87 million capital raise to support exploration activities
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Artemis Resources Limited (ARV) ORDINARY FULLY PAID |
Materials |
$18 |
Quarterly Cash Flow Report
|
30 Jul 2024 10:18AM |
$0.010 |
$0.007 |
fallen by
30%
|
|
ARV - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash outflow from operating activities: $358,000
- Net cash outflow from investing activities: $950,000
- Net cash inflow from financing activities: $1.1 million
- Cash and cash equivalents at the end of the period: $556,000
- Total payments to related parties: $126,000
- Secured an additional $1.6 million in July 2024
- Company believes it has adequate funding to continue operations
- Cash used in settlement of Osborne Lithium JV drilling costs: $400,000
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cyclone Metals Limited (CLE) ORDINARY FULLY PAID |
Materials |
$50 |
Quarterly Activities Report and Appendix 5B
|
30 Jul 2024 10:15AM |
$0.001 |
$0.046 |
risen by
4,500%
|
|
CLE - Price-sensitive ASX Announcement
Full Release
Key Points
- Cyclone Metals Limited raised $1.87 million through a placement.
- Plans to raise an additional $5.39 million through an entitlement offer.
- Conducted comprehensive site visits to key infrastructure for Iron Bear project.
- Evaluated the Pointe Noire Iron Ore Export Port and Menihek Hydropower Plant.
- Proposed a share consolidation to enhance capital structure.
- Secured funding to advance Iron Bear project and support working capital needs.
- Strategic discussions with port operators to enhance efficiency.
- Cyclone aims to establish a JV with a Tier 1 miner or steel mill.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| PM Capital Global Opportunities Fund Limited (PGF) ORDINARY FULLY PAID |
Financials |
$1,194 |
PGF Placement and Share Purchase Plan Investor Presentation
|
30 Jul 2024 10:13AM |
$2.340 |
$2.490 |
risen by
6.41%
|
|
PGF - Price-sensitive ASX Announcement
Full Release
Key Points
- Non-underwritten placement to raise approximately $100 million.
- Share Purchase Plan to raise up to $20 million.
- Offer price set at $2.19 per new share.
- Discount of 6.4% to the last traded price of $2.34.
- Minimum dividend guidance of 10 cents per share per annum, fully franked.
- Retained earnings and profit reserves sufficient for 7.8 years of future dividends.
- Capital raised will be invested according to the existing strategy managed by PM Capital.
- The new shares will provide greater market liquidity and brokerage-free increase in shareholding.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Gas2Grid Limited (GGX) ORDINARY FULLY PAID |
Energy |
$4 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jul 2024 10:11AM |
$0.001 |
$0.001 |
fallen by
0%
|
|
| Hastings Technology Metals Limited (HAS) ORDINARY FULLY PAID |
Materials |
$64 |
Quarterly Activities Report
|
30 Jul 2024 10:10AM |
$0.305 |
$0.340 |
risen by
11.48%
|
|
HAS - Price-sensitive ASX Announcement
Full Release
Key Points
- Cost review reduced the remaining capital cost for the Yangibana Rare Earths Project to $320 million.
- Identified $56 million in total savings.
- Completed a pro-rata renounceable rights issue raising $15.88 million.
- Had $21.8 million in cash as of 30 June 2024.
- JL Mag to become a 9.8% strategic investor in Hastings.
- Received a quarterly dividend of CAD 762,800 from Neo Performance Materials.
- High-grade heavy rare earths recognized from surface at Centipede Range.
- Implemented organisational restructuring to align with strategy and deliver cost savings.
- Total Recordable Injury Frequency Rate of 0.0 for FY2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| DXN Limited (DXN) ORDINARY FULLY PAID |
Information Technology |
$9 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jul 2024 10:09AM |
$0.074 |
$0.031 |
fallen by
58.11%
|
|
DXN - Price-sensitive ASX Announcement
Full Release
Key Points
- DXN reported total revenue of $3.8m for 4Q24, marking a 145% increase over 4Q23.
- FY24 revenue increased by 41% to $10.9m, driven by new modular data centre sales.
- Net operating cash flows were positive at $1.04m for 4Q24 and $327k for FY24, a first in DXN's history.
- FY24 unaudited EBITDA is expected to be $402k compared to FY23 losses of $4.9m; underlying EBITDA is $1.2m after adjustments.
- DXN completed its exit from the Sydney Data Centre, saving approximately $1.4m annually in lease costs.
- 4Q24 saw $3.1 million in modular revenue, contributing to a total of $8m for FY24.
- Signed a $5.7m contract for four Cable Landing Stations for the East Micronesia Cable System, the largest in DXN's history.
- Evaluating strategic options for the data centre business.
- Payments included $1.461m for product manufacturing, $662k for staff costs, $799k for administration, and $346k for leased assets.
- Cash balance as of 30 June 2024 was $2.98m.
- Board appointments: Abigail Cheadle as Non-Executive Director and Chair, Shalini Lagrutta as CEO and Managing Director, and Laila Green as Interim CFO.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Syntara Limited (SNT) ORDINARY FULLY PAID |
Health Care |
$120 |
Equity Raising Presentation
|
30 Jul 2024 10:09AM |
$0.040 |
$0.074 |
risen by
85%
|
|
SNT - Price-sensitive ASX Announcement
Full Release
Key Points
- Equity raising to fund clinical programs
- Sale of Mannitol business unit to Arna Pharma
- Clinical trials for SNT-5505
- Myelofibrosis and Myelodysplastic Syndrome trials
- Investment and shareholder approval needed for KP Rx
- Cost savings and operational changes post-MBU sale
- Board leadership and experience
- Risk factors associated with clinical trials and product approval
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Firebird Metals Limited (FRB) ORDINARY FULLY PAID |
Materials |
$11 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jul 2024 10:09AM |
$0.115 |
$0.075 |
fallen by
34.78%
|
|
FRB - Price-sensitive ASX Announcement
Full Release
Key Points
- Progress on Battery Grade Manganese Sulphate Feasibility Study in China
- Projected CAPEX of US$83.5 million and OPEX of US$609/mt
- Strong financial support from Jinshi Government and China Construction Bank
- Key safety and environmental permits advancing
- Operations expected to commence in late 2025 or early 2026
- Cash position at the end of June 2024 was $5.1 million
- Agreement signed with Zhongji Sunward Technology for energy-saving calcining technologies
- Farm-out agreement with Macro Metals on non-core manganese tenements
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Rincon Resources Limited (RCR) ORDINARY FULLY PAID |
Materials |
$4 |
Response to ASX Price and Volume Query
|
30 Jul 2024 10:09AM |
$0.077 |
$0.014 |
fallen by
82.47%
|
|
RCR - Price-sensitive ASX Announcement
Full Release
Key Points
- RCR is unaware of any undisclosed information explaining recent trading activity.
- Recent drilling results from West Arunta Project received and reviewed.
- Requested trading halt to finalize and approve disclosure before market open.
- Confirmed compliance with ASX Listing Rules and continuous disclosure policies.
- Noted investor anticipation of drilling updates and significant interest in potential niobium mineralization.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Rincon Resources Limited (RCR) ORDINARY FULLY PAID |
Materials |
$4 |
Pokali Drilling Results, West Arunta Project
|
30 Jul 2024 10:09AM |
$0.077 |
$0.014 |
fallen by
82.47%
|
|
RCR - Price-sensitive ASX Announcement
Full Release
Key Points
- Multiple zones of anomalous copper mineralisation were intersected in both reverse circulation and diamond drilling at Pokali East, Pokali North, and Jewel.
- Evidence indicates a potentially extensive Iron Oxide Copper-Gold (IOCG) system at Pokali.
- Significant intercepts include up to 7m at 0.15% Cu and up to 10m at 0.20% Cu.
- Zoned alteration and trace element signatures indicative of IOCG mineral systems were identified at Pokali East and Pokali North.
- A strong copper pathfinder element suite was established, aiding in targeting high-grade copper mineralisation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Hastings Technology Metals Limited (HAS) ORDINARY FULLY PAID |
Materials |
$64 |
Quarterly Cash Flow Report
|
30 Jul 2024 10:07AM |
$0.305 |
$0.340 |
risen by
11.48%
|
|
HAS - Price-sensitive ASX Announcement
Full Release
Key Points
- Cash outflows for development, exploration, and evaluation activities.
- Receipt of $280,000 from government grants and tax incentives.
- Proceeds from the issuance of equity securities amounting to $15.9 million.
- Investment in property, plant, and equipment totaling $12.75 million for the quarter.
- The company has $21.8 million in cash and cash equivalents at the end of the quarter.
- Unused financing facilities were unavailable at the quarter's end.
- The estimated quarters of funding available are 3.4 quarters.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Kingston Resources Limited (KSN) ORDINARY FULLY PAID |
Materials |
$76 |
Open Pit Ore Commissioning Underway at Mineral Hill
|
30 Jul 2024 10:05AM |
$0.075 |
$0.092 |
risen by
22.67%
|
|
KSN - Price-sensitive ASX Announcement
Full Release
Key Points
- Kingston Resources Limited has started processing hard rock ore at the Mineral Hill processing plant.
- The transition from tailings retreatment to open pit mining at Pearse North was successfully completed within eight weeks.
- Over 25,000 tonnes of oxide open pit ore has been stockpiled ready for processing.
- The plant refurbishment was carried out using in-house expertise, optimizing resource use.
- Increased production of gold and silver is expected following full commissioning.
- The team has also transitioned tailings mining workforce to open pit mining and employed additional workers.
- Local recruitment is prioritized to build a skilled workforce at Mineral Hill.
- The Mineral Resource Estimate for Pearse North was updated, increasing contained gold by 30% and silver by 67%.
- Enhanced economic development is expected within the local Condobolin community and Lachlan Shire.
- The first blast at Pearse North was fired on June 11, and processing circuit commissioning is now underway.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Syntara Limited (SNT) ORDINARY FULLY PAID |
Health Care |
$120 |
Proposed issue of securities - SNT
|
30 Jul 2024 10:05AM |
$0.040 |
$0.074 |
risen by
85%
|
|
| Syntara Limited (SNT) ORDINARY FULLY PAID |
Health Care |
$120 |
Placement
|
30 Jul 2024 10:05AM |
$0.040 |
$0.074 |
risen by
85%
|
|
SNT - Price-sensitive ASX Announcement
Full Release
Key Points
- Syntara Limited has received firm commitments to raise approximately A$5.0 million via a two-tranche placement at A$0.028 per share.
- Funds raised will ensure the completion of Syntara’s Phase 2 clinical trials.
- The total amount currently claimed by Syntara from the acquiror Arna Pharma Pty Ltd is approximately A$5.1 million.
- Clinical trials include myelofibrosis (MF), myelodysplastic syndrome (MDS), skin scarring, and iRBD/Parkinson’s disease.
- Syntara's post-deal cash balance is expected to be approximately A$8.5 million.
- The placement will be issued within the Company’s 15% placement capacity under ASX Listing Rule 7.1.
- Tranche 2 includes a A$1.5 million investment by KP Rx, requiring shareholder approval.
- The placement was necessitated by a challenge from Arna Pharma regarding amounts claimed by Syntara.
- Syntara’s lead drug asset, SNT-5505, is progressing in Phase 2 clinical trials.
- Syntara is developing treatments for several high unmet need diseases and has sold its respiratory product business.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Discovery Alaska Limited (DAF) ORDINARY FULLY PAID |
Materials |
$3 |
Quarterly Activities / Cashflow Report
|
30 Jul 2024 10:04AM |
$0.013 |
$0.011 |
fallen by
15.38%
|
|
DAF - Price-sensitive ASX Announcement
Full Release
Key Points
- Vinasale Gold Project contains historic NI 43-101 inferred and indicated resources.
- The project has exploration upside to expand resources and follow-up on additional target zones.
- Discovery Alaska Limited has 100% rights to the Vinasale Gold Project and Chulitna Project, both located in Alaska, USA.
- Review works involved an audit and correlation of the historic resource block model and drillhole data.
- New targets for potential separate zones of mineralization identified.
- Company's current cash reserves are around $0.49 million.
- Prudent financial management maintained by Discovery Alaska Limited.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tamboran Resources Corporation (TBN) CDI 200:1 US PERSON PROHIBITED EXCLUDING QIB |
Energy |
$241 |
Partial Exercise of Underwriters Over-Allotment Option
|
30 Jul 2024 10:00AM |
$0.185 |
$0.173 |
fallen by
6.76%
|
|
TBN - Price-sensitive ASX Announcement
Full Release
Key Points
- Tamboran Resources Corporation announced the partial exercise of underwriters' over-allotment option.
- Underwriters partially exercised their option to purchase an additional 308,750 shares at US$24.00 each.
- The closing of this exercise is expected on July 30, 2024, subject to customary closing conditions.
- The over-allotment option was connected to Tamboran's IPO of 3,125,000 shares of common stock priced at US$24.00 per share.
- The company expects gross proceeds of US$7.4 million from this offering.
- The proceeds will be used to fund the ongoing drilling activities for the Shenandoah South Pilot Project in the Beetaloo Basin.
- A registration statement on Form S-1 relating to the offering was declared effective by the SEC on June 26, 2024.
- The press release clarifies that it does not constitute an offer to sell or buy securities outside of proper registration or qualification.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Carnegie Clean Energy Limited (CCE) ORDINARY FULLY PAID |
Utilities |
$15 |
Monthly Activities/Appendix 4C Cash Flow Report
|
30 Jul 2024 9:59AM |
$0.044 |
$0.041 |
fallen by
6.82%
|
|
CCE - Price-sensitive ASX Announcement
Full Release
Key Points
- Carnegie successfully raised $2.134 million in June through a Share Purchase Plan.
- The ACHIEVE Programme is progressing towards the 2025 deployment of the first CETO unit in Europe.
- Carnegie featured at the HPE Discover 2024 conference in Las Vegas.
- MoorPower Scaled Demonstrator underwent winter testing and achieved significant operational data.
- Large Scale Generation Certificates from Garden Island Microgrid generated $117,616 in revenue.
- Carnegie had $3.729m in cash reserves at the end of the quarter.
- Payments to related parties and their associates during the quarter totaled approximately $73.8k.
- The ACHIEVE Programme involves detailed design and procurement of key components for the CETO technology.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bhagwan Marine Limited (BWN) ORDINARY FULLY PAID |
Industrials |
$129 |
Notice of Initial Substantial Holder - Kannikoski
|
30 Jul 2024 9:59AM |
$0.049 |
$0.470 |
risen by
859.18%
|
|
| PM Capital Global Opportunities Fund Limited (PGF) ORDINARY FULLY PAID |
Financials |
$1,194 |
Proposed issue of securities - PGF
|
30 Jul 2024 9:59AM |
$2.340 |
$2.490 |
risen by
6.41%
|
|
| PM Capital Global Opportunities Fund Limited (PGF) ORDINARY FULLY PAID |
Financials |
$1,194 |
Dividend Guidance
|
30 Jul 2024 9:58AM |
$2.340 |
$2.490 |
risen by
6.41%
|
|
PGF - Price-sensitive ASX Announcement
Full Release
Key Points
- Reaffirmation of intention to deliver minimum 10.0 cents fully franked dividend for Financial Year 2024
- Final full-year dividend for Financial Year 2024 to be at least 5.0 cents fully franked
- Forward dividend guidance for Financial Year 2025: minimum 10.0 cents fully franked dividend
- Financial Year 2024 portfolio return of 24.5%
- Retained earnings and profit reserves sufficient for 7.8 years at current semi-annual dividend rate
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Fluence Corporation Limited (FLC) ORDINARY FULLY PAID |
Utilities |
$43 |
FLC repays Upwell loan in full & secures revolving credit
|
30 Jul 2024 9:57AM |
$0.130 |
$0.040 |
fallen by
69.23%
|
|
FLC - Price-sensitive ASX Announcement
Full Release
Key Points
- Full repayment of Loan Facility with Upwell Water LLC
- Repayment includes Upwell Facility and Bimini Project Loan totaling US $14.25 million
- Termination of Upwell Facility and release of all collateral
- Upwell retains option to finance future Build-Own-Operate (BOO) projects
- Secured new revolving credit facility up to US $15.0 million on more favorable terms
- Revolving facility initially for 21 months with a possible extension
- Interest rate variable, currently pegged to US Prime Rate at 8.5%
- Provides working capital and project financing moving forward
- Involvement of board members Niko Oldendorff and Doug Brown in the new facility.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Hydrix Limited (HYD) ORDINARY FULLY PAID |
Information Technology |
$4 |
Quarterly Activities Report/Appendix 4C and Trading Update
|
30 Jul 2024 9:57AM |
$0.014 |
$0.015 |
risen by
7.14%
|
|
HYD - Price-sensitive ASX Announcement
Full Release
Key Points
- Excellent sales conversion progress in cardiac and medtech sales pipeline.
- Lowered annualised operating cost base while retaining specialised product development know-how.
- Significant progress in contracting sales with $4.7m for the quarter and $11.2m for FY24.
- 22% of the sales opportunity pipeline is now qualified, up 20% from the March quarter.
- 90% of sales are from Europe and the USA.
- Revenues for the quarter were $2.4m, down 26% compared to the previous corresponding period.
- Sales of 5 LUDO mechanical heart controller units.
- Group initiatives reduced the annualised operating cost basis by approximately $1.7m.
- Hydrix Ventures holds $5.1m in net venture capital assets across three medtech companies.
- Hydrix Medical's sales pipeline for Implicity’s remote cardiac patient monitoring software exceeds $2.5m.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
